comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 17:20:14 - browse：89

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： The painfully weak evidence on taking collagen to treat arthritis

WSS

Discs beat pads, tampons for heavy menstrual flow, new study shows

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Travel bans should be based on evidence, not politics or fear

Germany receives 178 compensation applications from gay servicepeople over discrimination

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Dairy farmers resist CDC push for PPE against bird flu virus

explore

comprehensive

explore

Duchenne breakthrough therapy leaves behind pioneering families

Sage's campaign to raise awareness of postpartum depression hits a nerve

In age of alternative facts, a scholarly course on calling out crap

Biden praises World Series champion Astros for impact off the field during White House celebration

BioMarin wins approval for gene therapy to treat hemophilia A

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Telehealth startups turn to complex chronic diseases

How one medical school became remarkably diverse

Study: Adult vaccinations pay for themselves in societal benefits

explore

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

The painfully weak evidence on taking collagen to treat arthritis

Making AI in medicine accessible to smaller, and rural hospitals

Sanofi strikes deal with Novavax, boosting the vaccine maker

Sanofi strikes deal with Novavax, boosting the vaccine maker

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

hotspot

focus

Wikipedia

focus